The PALD1 Gene: A Potential Drug Target for Various Diseases (G27143)

Target Name: PALD1

NCBI ID: G27143

PALD1

The PALD1 Gene: A Potential Drug Target for Various Diseases

PALD1 (Protein-AminoLipid dynamic transporter 1) gene is a gene that plays an important role in the human body. It plays a role in regulating various physiological processes in organisms, such as energy metabolism, cell signaling and immune response. The protein encoded by the PALD1 gene is a lipid transport protein whose main function is to participate in the transport and metabolism of lipids. In a variety of diseases, the PALD1 gene has been discovered as a potential drug target or biomarker. This article will discuss the role of the PALD1 gene and its significance in drug research and clinical application.

Function and structure of PALD1 gene

The PALD1 gene belongs to the PALIPRIDE family, and members of this family play an important role in the transport of biomolecules in organisms. The protein encoded by the PALD1 gene is a protein composed of 494 amino acids with a molecular weight of 51.9 kDa. The PALD1 protein consists of two structural domains: the N-terminal 伪-helix and the C-terminal 尾-coil. In addition, the PALD1 protein also contains a central 尾-coil, as well as an N-terminal 伪-helix and a C-terminal domain.

Pathological role of PALD1 gene

Variations in the PALD1 gene are associated with the occurrence of various diseases. Studies have found that variations in the PALD1 gene are related to many diseases, such as obesity, diabetes, cardiovascular disease and neurodegenerative diseases. Variations in the PALD1 gene may also be related to the occurrence of certain cancers, such as lung cancer, liver cancer, and breast cancer.

Drug targets of the PALD1 gene

The protein of the PALD1 gene plays an important transport role in organisms and is therefore considered a potential target for many drugs. Many studies have explored the use of the PALD1 gene in drug screening and treatment. For example, studies have found that knockdown of the PALD1 gene is associated with the onset of hyperlipidemia and diabetes. In addition, the PALD1 gene has also been used as a potential drug target to treat various diseases, such as the relationship between PALD1 gene knockdown and obesity and diabetes, and the relationship between PALD1 gene and cancer.

Clinical application of PALD1 gene

Knockdown of the PALD1 gene has been shown to be associated with a variety of diseases, such as obesity, diabetes, cardiovascular disease, and neurodegenerative diseases. Therefore, the PALD1 gene is widely studied to find new treatments and drugs. The PALD1 gene has also been used as a potential drug target to treat various diseases. For example, researchers are exploring the use of the PALD1 gene in treating obesity, diabetes and cardiovascular disease. In addition, knockdown of the PALD1 gene has also been used as a potential drug target for the treatment of certain cancers.

in conclusion

The PALD1 gene plays an important role in organisms and plays an important role in the occurrence of various diseases. The protein encoded by the PALD1 gene is a lipid transport protein whose main function is to participate in the transport and metabolism of lipids. Variations in the PALD1 gene are associated with the occurrence of a variety of diseases and are therefore considered potential targets for many drugs. Knockdown of the PALD1 gene has been shown to be associated with various diseases such as obesity, diabetes, cardiovascular disease, and neurodegenerative diseases. Therefore, the PALD1 gene has been widely studied to find new treatments and drugs, and is expected to become a potential drug target for the treatment of obesity, diabetes, cardiovascular disease and other diseases.

Protein Name: Phosphatase Domain Containing Paladin 1

The "PALD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PALD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets